Ankur Patel

Ankur Patel

Auto-generated profile, based on publicly available information

Ankur Patel

Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore; Duke-NUS Graduate Medical School, Singapore

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Radiology
Verified
Journal Article
Closed access
APAnkur Patel
Ankur Patel
FIFarah G. Irani
Farah G. Irani
UPUei Pua
Uei Pua
KTKiang Hiong Tay
Kiang Hiong Tay
TCTze Tec Chong
Tze Tec Chong
BTBien Soo Tan
Bien Soo Tan
Drug-coated balloons in below-the-knee arteries in patients with critical limb ischemia conferred no benefit over conventional balloon angioplasty in 6-month primary patency, with poorer amputation... Background There is a paucity of randomized trials demonstrating superior efficacy of drug-coated balloon angioplasty (DCBA) compared with conventional percutaneous transluminal angioplasty (PTA) f...

1 August 2021 in British Journal of Radiology
Verified
Journal Article
Closed access
QLQiqi Lu
Qiqi Lu
SLSum Leong
Sum Leong
KLKristen Alexa Lee
Kristen Alexa Lee
APAnkur Patel
Ankur Patel
JCJasmine Ming Er Chua
Jasmine Ming Er Chua
CTChow Wei Too
Chow Wei Too
Hepatic venous pressure gradient (HVPG) is the gold-standard for measurement of portal hypertension, a common cause for life-threatening conditions such as variceal bleeding and hepatic encephalopathy. HVPG also plays a crucial role in risk stratification, treatment selection and assessment of treatment response. Thus recognition of common pitfalls and unusual hepatic venous conditions is crucial. This article aims to provide a radiographical and clinical guide to HVPG with representative clinical cases.

1 January 2018 in Journal of Urology
Verified
Journal Article
Open access
TGThomas W. Gaither
Thomas W. Gaither
APAnkur Patel
Ankur Patel
CPChandni Patel
Chandni Patel
KCKai-Wen Chuang
Kai-Wen Chuang
RCRonald A. Cohen
Ronald A. Cohen
LBLynae Baskin
Lynae Baskin
We evaluated predictive factors for compensatory hypertrophy and renal outcomes in a large cohort of patients with multicystic dysplastic kidneys. We conducted a retrospective review from 1997 to 2016. Contralateral kidney and multicystic dysplastic kidney length were recorded from all ultrasounds as well as creatinine when available. We used generalized estimating equations to determine predictors of contralateral kidney length. A total of 443 children with multicystic dysplastic kidneys were identified based on sonographic findings and lack of function on nuclear scan. Average followup was 3.2 years (IQR 1.5 to 5.7). Median time to involution in patients diagnosed before age 2 years was 5.5 years (95% CI 3.8-7.0). In all patients the median time to contralateral hypertrophy was 2.7 years (95% CI 2.2-3.3), and 90% of patients manifested contralateral hypertrophy by 10 years. After adjusting for age, gender, multicystic dysplastic kidney side and cohort status for each year of involution after age 2 years, the contralateral kidney grows 0.35 cm longer (95% CI 0.01-0.68, p = 0.04) compared to cases without involution. Patients with contralateral hypertrophy had greater creatinine clearance at followup (83 vs 61 ml per minute, p = 0.07), although this finding was not statistically significant due to limited data. The majority of children with multicystic dysplastic kidneys will have contralateral hypertrophy by age 3 years. Multicystic dysplastic kidney involution predicts contralateral kidney growth rate after age 2 years. A small cohort of patients with multicystic dysplastic kidneys will not exhibit contralateral hypertrophy and may be at risk for renal insufficiency.

27 April 2020 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
CTChow Wei Too
Chow Wei Too
DWDavid Wei Wen
David Wei Wen
APAnkur Patel
Ankur Patel
ASAbdul Rahman Abdul Syafiq
Abdul Rahman Abdul Syafiq
JLJian Liu
Jian Liu
KTKiang Hiong Tay
Kiang Hiong Tay
With astonishing speed, COVID-19 has become a global pandemic. As it is uncertain when the pandemic will be controlled, it is crucial for procedurists of all stripes to be familiar and confident in performing procedures for COVID-19 patients to prevent intra-hospital infection. In this article, we will detail our approach on how to perform interventional procedures for COVID-19 patients at the bedside in the isolation room and with the patient transferred to the interventional radiology centre. These workflows have been developed in conjunction with multiple other stakeholders within our hospital, drawing from valuable lessons we have learnt from the SARS outbreak of 2003.

1 October 2021 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
KFKhi Yung Fong
Khi Yung Fong
JZJoseph J Zhao
Joseph J Zhao
ETEelin Tan
Eelin Tan
NSNicholas L. Syn
Nicholas L. Syn
RSRehena Sultana
Rehena Sultana
CTChow Wei Too
Chow Wei Too

3 December 2018 in CVIR Endovascular
Verified
Journal Article
Open access
PDF file
RJRavi Kumar Muli Jogi
Ravi Kumar Muli Jogi
KDKarthikeyan Damodharan
Karthikeyan Damodharan
HLHing Lun Leong
Hing Lun Leong
ATAllison Chek Swee Tan
Allison Chek Swee Tan
SCSivanathan Chandramohan
Sivanathan Chandramohan
TUThijs August Johan Urlings
Thijs August Johan Urlings
Acute limb ischemia is associated with significant mortality and amputation rate. Early restoration of flow can be obtained by various treatment methods that include catheter-directed thrombolysis (CDT) and percutaneous mechanical thrombectomy (PMT). These treatments have been shown to be effective but associated with various complications. There is lack of data comparing these two treatments. We aim to review our experience in the treatment of acute limb ischemia (ALI) and compare CDT with PMT. A total of 94 patients [mean age 65 years, 67% male (n = 63)] presented with ALI between 2006 and 2015 and were treated with either CDT or PMT. Outcomes were retrospectively reviewed. Primary outcomes were technical and clinical success; secondary outcomes were amputation rate at 30 days, duration of hospitalization and 30-day mortality. A total of 117 procedures were performed in 94 patients: 27 surgical bypass grafts, 31 previously stented arteries and 59 native vessels. Twenty eight procedures (24%) were performed with PMT, and 89 (76%) procedures were performed with CDT. Higher technical success was achieved in the PMT group (68%, 19/28) compared to the CDT group (47%, 42/89), p = 0.056. Clinical success was similar in both groups (75%, 21/28 in the PMT group and 73%, 65/89) in the CDT group (p = 0.837). There was no statistically significant difference in 30-day mortality between the PMT vs CDT groups (4% vs 8%, p = 0.425). The length of post-procedural hospital stay was shorter in patients with PMT (6.0 vs 12.6 days, p = 0.001). The absence of end-stage renal failure appears to be a predictor for clinical succes (HR 3.3, 95% CI 0.809–13.592). PMT is associated with higher technical success and significantly shorter length of stay compared to CDT; however, clinical success is similar across both treatment entities. The safety profile is comparable.